跳至主要内容
临床试验/jRCT1051220093
jRCT1051220093招募中不适用

A study of treatment of cancer cachexia and for reducing side effects of standard cancer treatment with human-derived mesenchymal stem cell conditioned medium

Seihoku Clinic0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20
主要终点
Common tumor markers

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18age 0month 0week old over 至 No limit(—)
性别
All

入选标准

  • Patients who want to reduce side effects associated with cancer cachexia and cancer treatment.
  • Patients who have been judged by the doctor to be optimally treated with conditioned medium.
  • <Inclusion criteria>
  • Target patients who meet the following criteria.
  • 18 years old and over
  • Have normal consent ability
  • Patients who can obtain their free will consent in writing
  • Patients whose doctor have recognized the need for treatment

排除标准

  • <Exclusion criteria>
  • Patient who meet any of the following conditions are excluded
  • Have a history of or suspected of dementia
  • Users of narcotics or stimulants
  • Pregnant, breastfeeding
  • Judged unsuitable by the doctor

结局指标

主要结局

Common tumor markers

Common tumor markers tested during previous treatment

次要结局

未报告次要终点

研究者

发起方
Seihoku Clinic

相似试验